Le Lézard
Classified in: Health, Business
Subject: VEN

Precision Orthopedics Receives Growth Equity Financing from Cobepa S.A.


LAUREL, Md., Jan. 13, 2020 /PRNewswire/ -- Cobepa S.A. ("Cobepa"), a global private equity firm, announced today that it has closed a growth equity investment in Precision Orthopedics ("Precision" or "the Company"), a leading provider of integrated orthopedic surgical care services across Maryland.

Precision will use the new capital to bolster its current operations and implement its expansion plans within Maryland and elsewhere. Dr. Rishi Bhatnagar, Founder and CEO of Precision, commented, "This partnership with Cobepa provides access to capital and strategic support for Precision's growth initiatives ? including expanding into new geographies, opening additional ambulatory surgery centers and partnering with additional hospitals. It will enhance our ability to reach and treat patients."

"Cobepa has a long history of supporting leading founder-led companies," said Peter Connolly, a Managing Director at Cobepa. "Dr. Bhatnagar and his team at Precision have done a remarkable job of building Precision into the leader it has become in a large and important geography. We are thrilled to partner with the Precision physicians in support of the Company's mission and growth objectives going forward."

Based in Laurel, Maryland, Precision is among the state's largest independent providers of clinical and surgical orthopedic treatment and ancillary patient care services. Utilizing a network of ten clinical locations, an ambulatory surgery center, and its deep hospital relationships, Precision provides a broad spectrum of comprehensive, patient-centric musculoskeletal care. Precision's comprehensive service line is administered by its deep team of highly trained physicians across the entire musculoskeletal spectrum, supported by the Company's long-tenured clinical support staff and strong physician leadership.

Cobepa North America team members Peter Connolly and Peter Batesko have joined Precision's Board of Directors. 

Duff & Phelps Securities, LLC and DLA Piper advised Precision. Choate, Hall & Stewart and Sheppard Mullin Richter & Hampton LLP provided legal counsel to Cobepa.

About Cobepa

Based in Brussels and New York, Cobepa is a privately?held investment company backed by European families. Cobepa manages a diversified portfolio of private equity investments valued at approximately $3.0 billion. Cobepa invests in leading companies with superior business models, sustainable market positions and leading management teams. Cobepa North America is primarily focused on investments in the healthcare and business services sectors as well as situations requiring a more nimble investment partner. For more information, visit www.cobepa.com.

SOURCE Cobepa


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: